SciVision Biotech Inc. (TPE:1786)
56.00
+2.50 (4.67%)
At close: Jul 9, 2026
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 4.19 billion as of July 9, 2026. Its market cap has decreased by -36.56% in one year.
Market Cap
4.19B
Enterprise Value
3.76B
Revenue
887.61M
Ranking
n/a
PE Ratio
32.68
Stock Price
56.00
Market Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 4.19B, an increase of 241.10%. That is a compound annual growth rate of 8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 4.19B | -20.05% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.11B |
| Medeon Biodesign | 7.10B |
| Pacific Hospital Supply | 5.90B |
| Formosa Optical Technology | 5.36B |
| St.Shine Optical | 4.88B |
| Bionime | 4.41B |
| Maxigen Biotech | 3.65B |
| ICARES Medicus | 3.60B |